Dutch biotech Fornix BioSciences said on Thursday it will sell its medical supplies unit Laprolan to Rochester Medical for 10.35 million euros ($13.5 million), largely completing the company's unwinding.
The sale completes a series of divestments Fornix launched early last year after it lost a...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.